At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Zymardrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
One Hour Preoperative Gatifloxacin
In Brief
A Phase 4 clinical trial evaluating Zymar for Ophthalmic Surgery. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Comparison of 1 day versus 1 hour application of topical Zymar.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOphthalmic Surgery
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2006
Enrollment StartJan 2007
Primary CompletionDec 2010
TodayJul 2026
First PostedJul 10, 2006
Enrollment StartJan 1, 2007
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 20.0 years ago
Interventions
Zymardrug
zymar qid